Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001609351-19-000045
Filing Date
2019-04-30
Accepted
2019-04-30 16:04:02
Documents
4
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A spark-201810xka.htm 10-K/A 921750
2 EXHIBIT 31.3 spark-20181231exx313.htm EX-31.3 21873
3 EXHIBIT 31.4 spark-20181231exx314.htm EX-31.4 21984
4 sparkproxy3a02.jpg GRAPHIC 20261
  Complete submission text file 0001609351-19-000045.txt   989272
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36819 | Film No.: 19781592
SIC: 2836 Biological Products, (No Diagnostic Substances)